Skip to content

Biodesix, Inc. BDSX Total Non-Current Liabilities

Total Non-Current Liabilities at other companies

NeoGenomics logo
NeoGenomicsNEO
$433.18M-0.1%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+462%
Enterprise value$279.56M+198%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s total non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s total non-current liabilities?
Biodesix, Inc. (BDSX) reported total non-current liabilities of $71.02M in Q1 2026.
How has Biodesix, Inc.'s total non-current liabilities changed year-over-year?
Biodesix, Inc.'s total non-current liabilities increased by 14.8% year-over-year, from $61.87M to $71.02M.
What is the long-term trend for Biodesix, Inc.'s total non-current liabilities?
Over 5 years (2020 to 2025), Biodesix, Inc.'s total non-current liabilities has grown at a 8.7% compound annual growth rate (CAGR), from $47.78M to $72.51M.
What does total non-current liabilities mean?
The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.